Treatment Registry
TR-0273 ActiveRecorded September 2, 2026

Compounded semaglutide

Sold by NativeMed · every compounded semaglutide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

What you actually pay

Per month

$149

Medication · 3 Month Starter, sale price$149

Added from the figures recorded below.

Price

TermPer monthCharged today
3 Month Starter, sale price

3 Month STARTER monthly $328 less $149/mo | $449 $179 paid upfront per month first month $159

source

Per month$149Charged today$179
Visit NativeMed

We earn nothing from this link. NativeMed has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

One reading so far. A price history appears here after the next verification pass.

  • September 2, 2026Entry added to the register

Sourcing and terms

PrescriberAsynchronous review
Cancellation“Absolutely! We understand that needs can change, so there are no long-term contracts or commitments beyond your chosen plan. Your satisfaction is our priority, and you’ll only be charged for medication that has already been shipped to you.”

Not yet checked: pharmacy, states, membership and consult fee.

Recorded from nativemed.net. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2, 2026Product titles are "Semaglutide: Injection Home Kit" and "Tirzepatide: Injection Home Kit" and homepage describes both as "Weekly at home injection," but neither page states vial vs. pen, so form is recorded as not-disclosed rather than assumed. The semaglutide product page's pricing widget text is visually garbled by the site's variant-selector markup (duplicate "Regular price" labels); the $149/mo figure is the clearly marked sale price for the 3-month starter plan. No page states which US states are served.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0273
Readings
1

Related records

Compounded semaglutide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 298 records of the same molecule.

Cite this entry

Treatment Registry. (2026). NativeMed compounded semaglutide (TR-0273). Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0273

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.